1. Zhu Q, Liao Y, Liao Z, Ye G, Shan C, Huang H. Compact bone mesenchymal stem cells-derived paracrine mediators for cell-free therapy in sepsis. Biochem Biophys Res Commun 2024; 727:150313.
2. Guo X, Schaudinn C, Blume-Peytavi U, Vogt A, Rancan F. Effects of adipose-derived stem cells and their conditioned medium in a human ex vivo wound model. Cells 2022; 11:1198-1221.
3. Wu S, Sun S, Fu W, Yang Z, Yao H, Zhang Z. The role and prospects of mesenchymal stem cells in skin repair and regeneration. Biomedicines 2024; 12:743-763.
4. Djavid GE, Tabaie SM, Tajali SB, Totounchi M, Farhoud A, Fateh M, et al. Application of a collagen matrix dressing on a neuropathic diabetic foot ulcer: A randomised control trial. J Wound Care 2020; 29:S13-S18.
5. Zhu C, Wu W, Qu X. Mesenchymal stem cells in osteoarthritis therapy: A review. Am J Transl Res 2021; 13:448-461.
6. Thomas MA, Fahey MJ, Pugliese BR, Irwin RM, Antonyak MA, Delco ML, et al. Human mesenchymal stromal cells release functional mitochondria in extracellular vesicles. Front Bioeng Biotechnol 2022; 10:870193.
7. Zhao Z, Zhang L, Ocansey DKW, Wang B, Mao F. The role of mesenchymal stem cell-derived exosome in epigenetic modifications in inflammatory diseases. Front Immunol 2023; 14:1166536.
8. Li Y-J, Xu Q-W, Xu C-H, Li W-M. MSC promotes the secretion of exosomal miR-34a-5p and improve intestinal barrier function through METTL3-mediated pre-miR-34A m6A modification. Mol Neurobiol 2022; 59:5222-5235.
9. Ebnerasuly F, Hajebrahimi Z, Tabaie SM, Darbouy M. Medicine C. Simulated microgravity condition alters the gene expression of some ECM and adhesion molecules in adipose derived stem cells. Int J Mol Cell Med 2018; 7:146-157.
10. Saccu G, Menchise V, Gai C, Bertolin M, Ferrari S, Giordano C, et al. Bone marrow mesenchymal stromal/stem cell-derived extracellular vesicles promote corneal wound repair by regulating inflammation and angiogenesis. Cells 2022; 11:3892-3915.
11. Rong X, Chu W, Zhang H, Wang Y, Qi X, Zhang G, et al. Antler stem cell-conditioned medium stimulates regenerative wound healing in rats. Stem Cell Res Ther 2019; 10:326-339.
12. Alinda MD, Christopher PM, Listiawan MY, Endaryanto A, Suroto H, Rantam FA, et al. The efficacy of topical adipose mesenchymal stem cell-conditioned medium versus framycetin gauze dressing in chronic plantar ulcer of leprosy: A randomized controlled trial. Indian J Dermatol Venereol Leprol 2023; 89:656-664.
13. Shams S, Shahrousvand M, Mohammadi-Rovshandeh J, Moghaddam AB, Heidari V, Esmaeili J. Encouraging collagen and epithelial layer formation via poly (lactic acid)/hyaluronic acid hybrid wound dressing containing niacinamide. Int J Biol Macromol 2025; 306:141463.
14. Nasiri N, Nateghi R, Zarei F, Hosseini S, Eslaminejad MB. Mesenchymal stem cell therapy for osteoarthritis: practice and possible promises. Adv Exp Med Biol 2022; 1387: 107-125.
15. Kol A, Wood JA, Carrade Holt DD, Gillette JA, Bohannon-Worsley LK, Puchalski SM, et al. Multiple intravenous injections of allogeneic equine mesenchymal stem cells do not induce a systemic inflammatory response but do alter lymphocyte subsets in healthy horses. Stem Cell Res Ther 2015; 6:73-81.
16. Huang X-P, Sun Z, Miyagi Y, McDonald Kinkaid H, Zhang L, Weisel RD, et al. Differentiation of allogeneic mesenchymal stem cells induces immunogenicity and limits their long-term benefits for myocardial repair. Circulation 2010; 122:2419-2429.
17. Clabaut A, Grare C, Léger T, Hardouin P, Broux O. Variations of secretome profiles according to conditioned medium preparation: The example of human mesenchymal stem cell‐derived adipocytes. Electrophoresis 2015; 36:2587-2593.
18. Smolinska V, Boháč M, Danisovic L. Current status of the applications of conditioned media derived from mesenchymal stem cells for regenerative medicine. Physiol Res 2023; 72:S233-S245.
19. Nasiri N, Haghdoost F, Habibi M, Fateh M, Gholami S, Tabaie SM. Stem Cell Perspective for Regenerative Wound Healing: from Biology toward Future Clinical Directions: A Review. Cell J 2024; 26: 575-589.
20. Peshkova M, Korneev A, Suleimanov S, Vlasova II, Svistunov A, Kosheleva N, et al. MSCs’ conditioned media cytokine and growth factor profiles and their impact on macrophage polarization. Stem Cell Res Ther 2023; 14:142-156.
21. Katagiri W, Sakaguchi K, Kawai T, Wakayama Y, Osugi M, Hibi H. A defined mix of cytokines mimics conditioned medium from cultures of bone marrow‐derived mesenchymal stem cells and elicits bone regeneration. Cell Prolif 2017; 50:e12333.
22. Ikhapoh IA, Pelham CJ, Agrawal DK. Synergistic effect of angiotensin II on vascular endothelial growth factor-A-mediated differentiation of bone marrow-derived mesenchymal stem cells into endothelial cells. Stem Cell Res Ther 2015; 6:4-16.
23. Noverina R, Widowati W, Ayuningtyas W, Kurniawan D, Afifah E, Laksmitawati DR, et al. Growth factors profile in conditioned medium human adipose tissue-derived mesenchymal stem cells (CM-hATMSCs). Med Sci Monit Basic Res 2019; 24:34-44.
24. Jin S, Yang C, Huang J, Liu L, Zhang Y, Li S, et al. Conditioned medium derived from FGF-2-modified GMSCs enhances migration and angiogenesis of human umbilical vein endothelial cells. Stem Cell Res Ther 2020; 11:68-79.
25. Drawina P, Putra A, Nasihun T, Prajoko YW, Dirja BT, Amalina ND. Increased serial levels of platelet‐derived growth factor using hypoxic mesenchymal stem cell‐conditioned medium to promote closure acceler‐ation in a full‐thickness wound. Indones. J Biotechnol 2022; 27:36-42.
26. Huang P, Zhang C, Delawary M, Korchak JA, Suda K, Zubair AC. Development and evaluation of IL‐6 overexpressing mesenchymal stem cells (MSCs). J Tissue Eng Regen Med 2022; 16:244-253.
27. Ding D-C, Liu H-W, Chu T-Y. Interleukin-6 from ovarian mesenchymal stem cells promotes proliferation, sphere and colony formation and tumorigenesis of an ovarian cancer cell line SKOV3. J Cancer 2016; 7:1815-1823.
28. Fusunyan RD, Quinn JJ, Ohno Y, MacDermott RP, Sanderson IR. Butyrate enhances interleukin (IL)-8 secretion by intestinal epithelial cells in response to IL-1β and lipopolysaccharide. Pediatr Res 1998; 43:84-90.
29. Sartipy P, Loskutoff DJ. Monocyte chemoattractant protein 1 in obesity and insulin resistance. Proc Natl Acad Sci U S A 2003; 100:7265-7270.
30. Zhan X, Zhang J, Li S, Zhang X, Li L, Song T, et al. Monocyte Chemoattractant Protein-1 stimulates the differentiation of rat stem and progenitor Leydig cells during regeneration. BMC Dev Biol 2020; 20:20-33.
31. Niada S, Giannasi C, Magagnotti C, Andolfo A, Brini A. Proteomic analysis of extracellular vesicles and conditioned medium from human adipose-derived stem/stromal cells and dermal fibroblasts. J Proteomics 2021; 232:104069.
32. Qiu G, Zheng G, Ge M, Wang J, Huang R, Shu Q, et al. Functional proteins of mesenchymal stem cell-derived extracellular vesicles. Stem Cell Res Ther 2019; 10:359-369.
33. Arasu UT, Kärnä R, Härkönen K, Oikari S, Koistinen A, Kröger H, et al. Human mesenchymal stem cells secrete hyaluronan-coated extracellular vesicles. Matrix Biol 2017; 64:54-68.
34. Gallo S, Gili M, Lombardo G, Rossetti A, Rosso A, Dentelli P, et al. Stem cell-derived, microRNA-carrying extracellular vesicles: a novel approach to interfering with mesangial cell collagen production in a hyperglycaemic setting. PLoS One 2016; 11:e0162417.
35. Acuto S, Lo Iacono M, Baiamonte E, Lo Re R, Maggio A, Cavalieri V. An optimized procedure for preparation of conditioned medium from Wharton’s jelly mesenchymal stromal cells isolated from umbilical cord. Front Mol Biosci 2023; 10:1273814.
36. He J, Cai Y, Luo L-M, Liu H-B. Hypoxic adipose mesenchymal stem cells derived conditioned medium protects myocardial infarct in rat. Eur Rev Med Pharmacol Sci 2015; 19: 4397-4406.
37. Bulati M, Miceli V, Gallo A, Amico G, Carcione C, Pampalone M, et al. The immunomodulatory properties of the human amnion-derived mesenchymal stromal/stem cells are induced by INF-γ produced by activated lymphomonocytes and are mediated by cell-to-cell contact and soluble factors. Frontiers in Immunology 2020; 11:54-73.
38. Driscoll J, Yan IK, Patel T. Development of a lyophilized off-the-shelf mesenchymal stem cell-derived acellular therapeutic. Pharmaceutics 2022; 14:849-859.
39. Lukomskyj AO, Rao N, Yan L, Pye JS, Li H, Wang B, et al. Stem cell-based tissue engineering for the treatment of burn wounds: A systematic review of preclinical studies. Stem Cell Rev Rep 2022; 18:1926-1955.
40. Nourian Dehkordi A, Mirahmadi Babaheydari F, Chehelgerdi M, Raeisi Dehkordi S. Skin tissue engineering: Wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther 2019; 10:1-20.
41. Huelsboemer L, Knoedler L, Kochen A, Yu CT, Hosseini H, Hollmann KS, et al. Cellular therapeutics and immunotherapies in wound healing–on the pulse of time?. Mil Med Res 2024; 11:23-47.
42. Jha KK, Raj A, Bishnoi H, Raj M, Thakur V, Chronic wound healing: A review of current management and treatments. Asian J Pharm Res Dev 2023; 11:95-102.
43. Deng Q, Du F, Pan S, Xia Y, Zhu Y, Zhang J, et al. Activation of angiopoietin-1 signaling with engineering mesenchymal stem cells promoted efficient angiogenesis in diabetic wound healing. Stem Cell Res Ther 2025; 16:75-90.
44. Humenik F, Maloveská M, Hudáková N, Petroušková P, Šufliarska Z, Horňáková Ľ, et al. Impact of canine amniotic mesenchymal stem cell conditioned media on the wound healing process: in vitro and in vivo study. Int J Mol Sci 2023; 24:8214-8227.
45. Wei Q, Liu M, Li S, Shi S, Du F, Peng H, et al. The composite biomatrix SC/CM improved the therapeutic effects of xenogeneic MSC on wound healing in immune-competent mice via immune niche reprogramming. J Mater Sci 2024; 59:15514-15528.
46. Gangadaran P, Oh EJ, Rajendran RL, Oh JM, Kim HM, Kwak S, et al. Three-dimensional culture conditioned bone marrow MSC secretome accelerates wound healing in a burn injury mouse model. Biochem Biophys Res Commun 2023; 673:87-95.
47. Hendrawan S, Kusnadi Y, Lagonda CA, Fauza D, Lheman J, Budi E, et al. Wound healing potential of human umbilical cord mesenchymal stem cell conditioned medium: An in vitro and in vivo study in diabetes-induced rats. Vet World 2021; 14:2109-2117.
48. Putra A, Ibrahim S, Muhar AM, Kuntardjo N, Dirja BT, Pasongka Z, et al. Topical gel of mesenchymal stem cells-conditioned medium under TNF-α precondition accelerates wound closure healing in full-thickness skin defect animal model. J Med Life 2022; 15:214-221.
49. Zhang S, Chen L, Zhang G, Zhang B. Umbilical cord-matrix stem cells induce the functional restoration of vascular endothelial cells and enhance skin wound healing in diabetic mice via the polarized macrophages. Stem Cell Res Ther 2020; 11:39-53.
50. Saheli M, Bayat M, Ganji R, Hendudari F, Kheirjou R, Pakzad M, et al. Human mesenchymal stem cells-conditioned medium improves diabetic wound healing mainly through modulating fibroblast behaviors. Arch Dermatol Res 2020; 312:325-336.
51. Fridoni M, Kouhkheil R, Abdollhifar MA, Amini A, Ghatrehsamani M, Ghoreishi SK, et al. Improvement in infected wound healing in type 1 diabetic rat by the synergistic effect of photobiomodulation therapy and conditioned medium. J Cell Biochem 2019; 120:9906-9916.
52. Chen C-Y, Rao S-S, Ren L, Hu X-K, Tan Y-J, Hu Y, et al. Exosomal DMBT1 from human urine-derived stem cells facilitates diabetic wound repair by promoting angiogenesis. Theranostics 2018; 8: 1607–1623.
53. Bagheri S, Squitti R, Haertlé T, Siotto M, Saboury AA. Role of copper in the onset of Alzheimer’s disease compared to other metals. Front Aging Neurosci 2018; 9:446-460.
54. Kouhkheil R, Fridoni M, Piryaei A, Taheri S, Chirani AS, Anarkooli IJ, et al. The effect of combined pulsed wave low‐level laser therapy and mesenchymal stem cell‐conditioned medium on the healing of an infected wound with methicillin‐resistant Staphylococcal aureus in diabetic rats. J Cell Biochem 2018; 119:5788-5797.
55. Ma D, Kua JEH, Lim WK, Lee ST, Chua AWC. In vitro characterization of human hair follicle dermal sheath mesenchymal stromal cells and their potential in enhancing diabetic wound healing. Cytotherapy 2015; 17:1036-1051.
56. Olivier M, Asmis R, Hawkins GA, Howard TD, Cox LA. The need for multi-omics biomarker signatures in precision medicine. Int J Mol Sci 2019; 20:4781-4793.
57. Tan ST, Aisyah PB, Firmansyah Y, Nathasia N, Budi E, Hendrawan SJJomh. Effectiveness of secretome from human umbilical cord mesenchymal stem cells in gel (10% SM-hUCMSC Gel) for chronic wounds (Diabetic and Trophic Ulcer)–Phase 2 clinical trial. J Multidiscip Healthc 2023:1763-1777.
58. Tan ST, Aisyah PB, Firmansyah Y, Nathasia N, Budi E, Hendrawan S. Effectiveness of secretome from human umbilical cord mesenchymal stem cells in gel (10% SM-hUCMSC Gel) for chronic wounds (Diabetic and Trophic Ulcer)–Phase 2 clinical trial. J Multidiscip Healthc 2023; 16: 1763-1777.
59. Alinda MD, Christopher PM, Listiawan MY, Endaryanto A, Suroto H, Rantam FA, et al. The efficacy of topical adipose mesenchymal stem cell-conditioned medium versus framycetin gauze dressing in chronic plantar ulcer of leprosy: A randomized controlled trial. Randomized Controlled Trial 2023; 89:656-664.
60. Azari Z, Nazarnezhad S, Webster TJ, Hoseini SJ, Brouki Milan P, Baino F, et al. Stem cell‐mediated angiogenesis in skin tissue engineering and wound healing. Wound Repair Regen 2022; 30:421-435.
61. Anbiyaiee A, Azizidoost S, Farzaneh M. Therapeutic potential of MSC-conditioned medium: A multifactorial approach to enhance wound healing. curr. Signal Transduct Ther 2024; 19:67-76.
62. Kumar P, Kandoi S, Misra R, Vijayalakshmi S, Rajagopal K, Verma RS. The mesenchymal stem cell secretome: A new paradigm towards cell-free therapeutic mode in regenerative medicine. Cytokine Growth Factor Rev 2019; 46:1-9.
63. Arifka M, Wilar G, Elamin KM, Wathoni N. Polymeric hydrogels as mesenchymal stem cell secretome delivery system in biomedical applications. Polymers (Basel) 2022; 14:1218-1236.
64. Montero-Vilchez T, Sierra-Sánchez Á, Sanchez-Diaz M, Quiñones-Vico MI, Sanabria-de-la-Torre R, Martinez-Lopez A, et al. Mesenchymal stromal cell-conditioned medium for skin diseases: a systematic review. Front Cell Dev Biol 2021; 9:654210.
65. Teixeira FG, Salgado AJ. Mesenchymal stem cells secretome: Current trends and future challenges. Neural Regen Res 2020; 15:75-77.
66. Chouaib B, Haack-Sørensen M, Chaubron F, Cuisinier F, Collart-Dutilleul P-Y. Towards the standardization of mesenchymal stem cell secretome-derived product manufacturing for tissue regeneration. Int J Mol Sci 2023; 24:12594.
67. Sagaradze G, Grigorieva O, Nimiritsky P, Basalova N, Kalinina N, Akopyan Z, et al. Conditioned medium from human mesenchymal stromal cells: towards clinical translation. Int J Mol Sci 2019; 20:1656-1671.
68. Brennan MÁ, Layrolle P, Mooney D. Biomaterials functionalized with MSC secreted extracellular vesicles and soluble factors for tissue regeneration. Adv Funct Mater 2020; 30:1909125.
69. Fernandes‐Platzgummer A, Cunha R, Morini S, Carvalho M, Moreno‐Cid J, García C, et al. Optimized operation of a controlled stirred tank reactor system for the production of mesenchymal stromal cells and their extracellular vesicles. Biotechnol Bioeng 2023; 120:2742-2755.
70. Huang Y, Li X, Yang L. Hydrogel encapsulation: taking the therapy of mesenchymal stem cells and their derived secretome to the next level. Front Bioeng Biotechnol 2022; 10:859927.
)